HSDT (Helius Medical Technologies Inc.) Final Profit

Official company branding of Helius Medical Technologies (HSDT)

Helius Medical is developing a business model that combines the sale of PoNS systems with high-margin SaaS support. The company is implementing neuromodulation in rehabilitation centers to assist in restoring motor skills. The primary challenges involve the struggle for insurance coverage and medical conservatism. The company's final net income confirms these fundamentals, with the figure reaching -0.16, helping investors filter out market noise.

Company Net Income: Helius Medical Technologies, Inc. (HSDT) for 07/04/2022 - 10/29/2026

Comprehensive metric breakdowns and analytics for heliusmedical.com (HSDT)

- stock value and consensus price forecast:
Market Price Helius Medical Technologies|HSDT - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Helius Medical Technologies, Inc.|HSDT - Enterprise Value
- business book valuation details:
Net Asset Value per Share Helius Medical Technologies|HSDT - Company Book Value|Market Value to Book Value Ratio heliusmedical.com|HSDT - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Helius Medical|HSDT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Helius Medical Technologies|HSDT - Company Debts|Debts to Net Assets Helius Medical Technologies, Inc.|HSDT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Helius Medical Technologies|Quick Liquidity Indicator heliusmedical.com
- company profitability and valuation multiples indicators:
HSDT - Net Profit
Basic company analysis:HSDT - Helius Medical Technologies Inc.
Mass-produced product of heliusmedical.com

This indicator tracks daily net income by measuring the difference between total revenues and all operating expenses to assess the actual efficiency of the business. By analyzing the overall profit of Helius Medical (HSDT), an investor can identify a critical working capital deficit caused by the slow adoption of the sole neurostimulator and challenges in securing insurance reimbursements.

Key competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|RGC: Final Profit|Net Profit AXSM|ACAD - Company Net Income|Company Net Income Xenon Pharmaceuticals Inc XENE|Viking Therapeutics Corp - Company Net Income|Supernus Pharmaceuticals - Net Profit|Net Financial Result catalystpharma.com CPRX|DNLI (Denali Therapeutics Inc.) - Net Income|Harmony Biosciences Inc (HRMY) - Net Profit|Company Net Income Biohaven Pharmaceutical|Amylyx Corp (AMLX) - Net Financial Result|Net Income TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Final Profit|Company Net Income Anavex Life Sciences Corp. AVXL|CBLL - Net Income|Prothena Biosciences - Net Profit|Company Net Income Alector, Inc.|ANNX: Net Profit|Company Profit OMER|NGNE (Neurogene) - Net Profit|AC Immune S.A. (ACIU) - Net Financial Result|Net Profit VYGR|Net Income Neumora Corp NMRA|Net Profit SCLX (Scilex Holding Company)|Net Profit tevogen.com TVGN|ACOG - Company Net Income|CGTX: Company Net Income|IKT: Net Profit|Cassava Pharma - Final Profit|Company Net Income Assertio Holdings|Coya (COYA) - Net Financial Result|Net Profit VTGN|ovidrx.com - Company Profit|Acumen Pharma - Net Income|Profit After Payment of Taxes CRVO (CervoMed Corporation)|ATHE - Company Net Income|CLNN (Clene Inc.) - Company Profit|PEPG: Net Profit|Company Net Income jupiterneurosciences.com (JUNS)|Net Income RLMD|Net Profit Annovis Bio Corporation|Company Net Income Grace Therapeutics, Inc. (GRCE)|AIFF (fireflyneuro.com) - Final Profit|Company Net Income Klotho Neurosciences KLTO|NeuroSense Therapeutics Ltd (NRSN) - Company Net Income|Reviva Pharmaceuticals Holdings - Net Profit|Final Profit MTVA (MetaVia Inc)|NRXS: Net Profit|Company Net Income Passage Bio (PASG)|Company Net Income Neuphoria Therapeutics, Inc.|Company Net Income NERV|Net Profit ATHA|Net Financial Result Addex|Alzamend Neuro - Net Income|Net Profit Cyclerion Therapeutics Inc. CYCN|PTIX - Company Net Income|Net Financial Result Pasithea Therapeutics KTTA|CRGT (cortigent.com) - Net Income|Avenue Therapeutics Inc - Final Profit|Company Net Income Brainstorm Cell|Net Income caratherapeutics.com (CARA)|Net Profit CHRO|ELYM - Company Net Income|Net Profit ITCI (Intra-Cellular Therapies, Inc.)|LBPH: Company Profit|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NRBO: Net Profit|Net Income Sage Therapeutics Inc.|SNPX (Neurotrope) - Net Profit|Net Profit Trevena Inc|Company Net Income Vigil Neuroscience (VIGL)|Company Net Income WENA (Anew Medical Inc.)|Net Profit CERE (Cerevel Therapeutics, Inc.)